By publishing its modern slavery statement for 2024, Hikma Pharmaceuticals demonstrates a commitment to addressing modern slavery risks in its supply chains, an important aspect of ethical business practices and human rights. This disclosure supports transparency and attempts to mitigate exploitation risks, reflecting a progressive step in supply chain ethics.

HIKMA PHARMACEUTICALS PUBLIC LIMITED COMPANY modern slavery statement summary (2024)

The profile also highlights a revolving door phenomenon, with all recorded Hikma lobbyists having prior government service. This practice raises concerns about potential conflicts of interest and the leveraging of insider knowledge to influence policy, which is viewed negatively from an anti-fascist and democratic accountability perspective.

Hikma Pharmaceuticals Profile: Summary • OpenSecrets

The reported $110,000 expenditure on lobbying suggests that Hikma Pharmaceuticals is actively engaging in efforts to influence federal policy, a practice that can consolidate corporate power and undermine democratic accountability. From an anti-fascist, progressive perspective, such political spending is concerning as it potentially supports an oligarchic influence on policymaking.

Hikma Pharmaceuticals Lobbying Profile • OpenSecrets

Hikma Pharmaceuticals has taken robust measures to review and enhance its supplier due diligence process and risk assessment criteria related to modern slavery. The creation of a Modern Slavery Taskforce, comprehensive supplier screening, and integration of advanced monitoring systems indicates a strong commitment to ethical supply chain practices and human rights, contributing positively to anti-fascist and ethical business practices.

Modern Slavery Act Statement

Hikma’s statement emphasizes a robust commitment to ethical standards and ESG priorities, including the protection of human rights and prevention of modern slavery practices. This proactive approach supports labor rights and corporate accountability, aligning with anti-fascist and progressive values by safeguarding marginalized groups and promoting transparency in business practices.

Acting responsibly

The company's disclosure and proactive stance on modern slavery and human trafficking prevention, as well as its commitment to humane animal testing, demonstrate strong ethical responsibility and respect for human rights. This positive policy approach supports marginalized communities and labor rights, aligning with anti-fascist and progressive principles.

Policy positions and statements